VITASPRING BIOMEDICAL CO., LTD. Deferred Income Tax Expense (Benefit)
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Deferred Income Tax Expense (Benefit) of $0 for the 12-month period ending 2024-01-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-12
- VITASPRING BIOMEDICAL CO., LTD. deferred income tax expense (benefit) for the quarter ending 2024-01-31 was $0.00.
- VITASPRING BIOMEDICAL CO., LTD. deferred income tax expense (benefit) for the quarter ending 2023-10-31 was $0.00.
- VITASPRING BIOMEDICAL CO., LTD. deferred income tax expense (benefit) for the quarter ending 2023-07-31 was $0.00, a 100.00% decline year-over-year.
- VITASPRING BIOMEDICAL CO., LTD. deferred income tax expense (benefit) for the quarter ending 2023-04-30 was $0.00.
- VITASPRING BIOMEDICAL CO., LTD. deferred income tax expense (benefit) for fiscal 2024 was $0.00.
- VITASPRING BIOMEDICAL CO., LTD. deferred income tax expense (benefit) for fiscal 2023 was -$6.18K, a 200.00% decline from fiscal 2022.
- VITASPRING BIOMEDICAL CO., LTD. deferred income tax expense (benefit) for fiscal 2022 was $6.18K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2024-01-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 |
| 2023-10-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-01-30 | $0.00 derived: sum of 2 quarters · filed 2026-01-30 | $0.00 10-Q · filed 2026-01-30 | -$4.47K derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-07-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-23 | $0.00 10-Q · filed 2026-01-23 | -$4.47K derived: sum of 3 quarters · filed 2026-03-12 | -$11.41K derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-04-30 | $0.00 10-Q · filed 2026-01-13 | -$4.47K derived: sum of 2 quarters · filed 2026-03-12 | -$11.41K derived: sum of 3 quarters · filed 2026-03-12 | -$5.37K derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-01-31 | -$4.47K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$11.41K derived: sum of 2 quarters · filed 2026-03-12 | -$5.37K derived: sum of 3 quarters · filed 2026-03-12 | -$6.18K 10-K · filed 2026-03-12 |
| 2022-10-31 | -$6.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-01-30 | -$901.00 derived: sum of 2 quarters · filed 2026-01-30 | -$1.71K 10-Q · filed 2026-01-30 | -$26.12K derived: sum of 4 quarters · filed 2026-01-30 |
| 2022-07-31 | $6.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-23 | $5.23K 10-Q · filed 2026-01-23 | -$19.19K derived: sum of 3 quarters · filed 2026-01-23 | $7.76K derived: sum of 4 quarters · filed 2026-01-23 |
| 2022-04-30 | -$807.00 10-Q · filed 2026-01-13 | -$25.22K derived: sum of 2 quarters · filed 2026-01-13 | $1.73K derived: sum of 3 quarters · filed 2026-01-13 | |
| 2022-01-31 | -$24.41K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-01 | $2.53K derived: sum of 2 quarters · filed 2025-12-01 | $6.18K 10-K · filed 2025-12-01 | |
| 2021-10-31 | $26.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-12-23 | $30.59K 10-Q · filed 2021-12-23 | ||
| 2021-07-31 | $3.65K 10-Q · filed 2021-09-15 | |||
| 2021-04-30 | -$56.25K 10-Q · filed 2021-06-14 | |||
| 2020-04-30 | $0.00 10-Q · filed 2021-06-14 |